Birth Control Recommendations for Protein S Deficiency
Women with protein S deficiency should use progestin-only intrauterine devices (IUDs) or copper IUDs as first-line contraception, and must strictly avoid all combined estrogen-progestin contraceptives due to significantly elevated thrombotic risk. 1
Primary Recommended Options
Levonorgestrel IUD (Preferred)
- Provides the highest efficacy (<1% pregnancy rate annually) with no increased thrombotic risk in women with thrombophilia 1
- Reduces menstrual bleeding, which is particularly beneficial if anticoagulation therapy is needed 2
- Does not require daily adherence, eliminating user-dependent failure 1
- Safe regardless of disease activity or other thrombotic risk factors 2
Copper IUD (Equally Safe Alternative)
- Completely hormone-free option with equivalent contraceptive efficacy (<1% failure rate) 1
- No hormonal effects on coagulation pathways 1
- May increase menstrual bleeding, which could be problematic if anticoagulation is required 1
Progestin-Only Pills (Less Preferred)
- Safe thrombotic profile in women with thrombophilia 1
- Lower efficacy (5-8% failure rate) due to strict adherence requirements—must be taken at the same time daily 1
- No increased venous thromboembolism risk (relative risk 0.90) 1
Absolutely Contraindicated Options
Combined Estrogen-Progestin Contraceptives (All Forms)
- Protein S deficiency represents a severe thrombophilia that creates unacceptable thrombotic risk when combined with estrogen 3, 4
- Women with protein S deficiency taking oral contraceptives have a 7-fold increased risk of venous thromboembolism compared to non-users 3
- Absolute VTE risk reaches 4.3-4.6 per 100 pill-years in women with severe thrombophilia (including protein S deficiency) using combined contraceptives 3
- Estrogen-containing contraceptives further decrease free protein S levels, compounding the existing deficiency 5, 6, 7
- This prohibition includes all delivery methods: oral pills, transdermal patches, and vaginal rings 1, 8
Depot Medroxyprogesterone Acetate (DMPA)
- Should be avoided due to higher VTE risk (relative risk 2.67) compared to other progestin-only methods 1
- Thrombotic risk approaches that of combined oral contraceptives 1
- Additional concern for bone mineral density loss with long-term use 1
Clinical Implementation Algorithm
Step 1: Confirm Diagnosis
- Document protein S deficiency with laboratory testing before contraceptive counseling 3, 4
- Assess for additional thrombotic risk factors (family history of VTE, personal history of thrombosis) 3
Step 2: First-Line Recommendation
- Offer levonorgestrel IUD as optimal choice 1, 2
- Explain <1% pregnancy rate and lack of thrombotic risk 1
- Emphasize benefit of reduced menstrual bleeding if anticoagulation is present 2
Step 3: Alternative if IUD Declined
- Copper IUD if patient prefers hormone-free option 1
- Progestin-only pills if patient cannot tolerate IUD, with strong counseling about daily adherence requirements 1
Step 4: Barrier Methods as Adjunct
- Recommend condoms for sexually transmitted infection protection regardless of primary method chosen 1
Critical Pitfalls to Avoid
- Never prescribe combined hormonal contraceptives to women with protein S deficiency, even if they request it—the thrombotic risk is unacceptable 3, 4
- Do not assume progestin implants are equivalent to other progestin-only methods—insufficient data exists for women with severe thrombophilia 1
- Avoid DMPA despite being progestin-only due to its unique thrombogenic profile 1
- Do not delay contraceptive counseling until after a thrombotic event occurs 3, 4
Emergency Contraception
- Levonorgestrel emergency contraception (Plan B) is safe and not contraindicated in protein S deficiency 1
- No medical contraindications exist for progestin-only emergency contraception 1
- Risks of emergency contraception are substantially lower than risks of unintended pregnancy 1
Special Considerations
If Anticoagulation Required
- Levonorgestrel IUD becomes even more advantageous due to menstrual bleeding reduction 2
- Copper IUD may worsen bleeding in anticoagulated patients 1